Expression levels of NF-Y target genes changed by CDKN1B correlate with clinical prognosis in multiple cancers. (Q53387038)

13 May 2018

title

Expression levels of NF-Y target genes changed by CDKN1B correlate with clinical prognosis in multiple cancers. (English)

1 reference

13 May 2018

author name string

Kazunori Yamanaka

1

1 reference

13 May 2018

Shinji Mizuarai

2

1 reference

13 May 2018

Tomohiro Eguchi

3

1 reference

13 May 2018

Hiraku Itadani

4

1 reference

13 May 2018

Hiroshi Hirai

5

1 reference

13 May 2018

Hidehito Kotani

6

1 reference

13 May 2018

publication date

25 June 2009

1 reference

13 May 2018

published in

Genomics

1 reference

13 May 2018

volume

94

1 reference

13 May 2018

issue

4

1 reference

13 May 2018

page(s)

219-227

1 reference

13 May 2018

Sibling rivalry in the E2F family

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2009.06.003

CDK inhibitors: positive and negative regulators of G1-phase progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2009.06.003

The INK4 family of cell cycle inhibitors in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2009.06.003

The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2009.06.003

5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2009.06.003

CDK inhibitors: cell cycle regulators and beyond

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2009.06.003

The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2009.06.003

Ubiquitin ligases: cell-cycle control and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2009.06.003

To cycle or not to cycle: a critical decision in cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2009.06.003

Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2009.06.003

Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2009.06.003

p27(Kip1) and cyclin E expression and breast cancer survival after treatment with adjuvant chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2009.06.003

E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2009.06.003

Role for E2F in control of both DNA replication and mitotic functions as revealed from DNA microarray analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2009.06.003

E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2009.06.003

E2Fs up-regulate expression of genes involved in DNA replication, DNA repair and mitosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2009.06.003

Isolating human transcription factor targets by coupling chromatin immunoprecipitation and CpG island microarray analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2009.06.003

Identification of novel pRb binding sites using CpG microarrays suggests that E2F recruits pRb to specific genomic sites during S phase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2009.06.003

Mechanisms of transcriptional regulation by Rb-E2F segregate by biological pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2009.06.003

Identification of target genes of the p16INK4A-pRB-E2F pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2009.06.003

RB silencing compromises the DNA damage-induced G2/M checkpoint and causes deregulated expression of the ECT2 oncogene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2009.06.003

Identification of genes periodically expressed in the human cell cycle and their expression in tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2009.06.003

TRANSFAC: transcriptional regulation, from patterns to profiles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2009.06.003

A census of mitotic cancer genes: new insights into tumor cell biology and cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2009.06.003

A gene-expression signature as a predictor of survival in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2009.06.003

Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2009.06.003

High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2009.06.003

Targeting the beta-catenin/TCF transcriptional complex in the treatment of multiple myeloma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2009.06.003

A molecular classification of papillary renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2009.06.003

Induction of p21(WAF1/CIP1) and inhibition of Cdk2 mediated by the tumor suppressor p16(INK4a)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2009.06.003

Induction of apoptosis in p16INK4A mutant cell lines by adenovirus-mediated overexpression of p16INK4A protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2009.06.003

p27Kip1 induces an accumulation of the repressor complexes of E2F and inhibits expression of the E2F-regulated genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2009.06.003

P21 functions to maintain quiescence of p27-deficient hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2009.06.003

Cdk2-dependent phosphorylation of the NF-Y transcription factor is essential for the expression of the cell cycle-regulatory genes and cell cycle G1/S and G2/M transitions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2009.06.003

Cdk2-dependent phosphorylation of the NF-Y transcription factor and its involvement in the p53-p21 signaling pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2009.06.003

Prognostic significance of p27KIP1 expression in resected non-small cell lung cancers: analysis in combination with expressions of p16INK4A, pRB, and p53

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2009.06.003

Aurora A on the mitotic spindle is activated by the way it holds its partner.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2009.06.003

Human pEg3 kinase associates with and phosphorylates CDC25B phosphatase: a potential role for pEg3 in cell cycle regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2009.06.003

MATCH: A tool for searching transcription factor binding sites in DNA sequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2009.06.003

The UCSC Genome Browser Database: 2008 update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2009.06.003

NCBI reference sequences (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2009.06.003

NetAffx: Affymetrix probesets and annotations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2009.06.003

Annotating the human proteome: the Human Proteome Survey Database (HumanPSD) and an in-depth target database for G protein-coupled receptors (GPCR-PD) from Incyte Genomics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2009.06.003

Gene ontology: tool for the unification of biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2009.06.003

10.1016/J.YGENO.2009.06.003

7 January 2021

Identifiers

DOI

1 reference

13 May 2018

release_3o2jphwuxzc6dectdjdstaa5am

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3o2jphwuxzc6dectdjdstaa5am

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

19559782

1 reference

13 May 2018